PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jun-2023 Topcon Healthcare Launches Customer Care Portal Businesswire
12-Jun-2023 Global Bio Decontamination Market Forecast to 2030: Players Include Fedegari Autoclavi, Howorth Air Technology, SolidFog Technologies and ClorDiSys Solutions - ResearchAndMarkets.com Businesswire
12-Jun-2023 Oral Proteins and Peptides Market Size to Hit $8.233 Billions by 2028 | Current Trends and Industry Analysis The Wire Times
12-Jun-2023 Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease Businesswire
12-Jun-2023 Element Expands Battery Testing Business in South Korea With Acquisition of NCT Businesswire
12-Jun-2023 Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing Businesswire
12-Jun-2023 Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL) Businesswire
12-Jun-2023 UPLIZNA® (inebilizumab-cdon) Pivotal Trial Publication Integrating MRI and Biomarker Evaluation Shows Accuracy and Uniformity of Attack Diagnoses for Neuromyelitis Optica Spectrum Disorder (NMOSD) Businesswire
12-Jun-2023 Armis Identifies Riskiest OT and ICS Devices Across Critical Infrastructure Industries Businesswire
12-Jun-2023 Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference Businesswire
12-Jun-2023 Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy Businesswire
12-Jun-2023 Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development Businesswire
12-Jun-2023 Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference Businesswire
12-Jun-2023 ONDEXXYA▼(ANDEXANET ALFA) PHASE IV TRIAL STOPPED EARLY AFTER ACHIEVING PRE-SPECIFIED CRITERIA ON HAEMOSTATIC EFFICACY VERSUS USUAL CARE AstraZeneca
12-Jun-2023 Quell Therapeutics Signs a Collaboration, Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Quell Therapeutics
12-Jun-2023 Modus Therapeutics presented new data on sevuparin demonstrating its potential to treat anemia related to chronic diseases at the annual European Hematology Association Congress Modus Therapeutics
12-Jun-2023 Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson's and motor neurone disease Samsara Therapeutics
12-Jun-2023 Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-NPC Program Bloomsbury Genetic Therapies
12-Jun-2023 Autolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and Innovation Autolomous
12-Jun-2023 Pioneering clinical trial service launched at PHTA University of Birmingham